ITALY, 15-Jul-2025 — /EuropaWire/ — An EU‑funded consortium of Italian and French partners has unveiled PANDORA, a pioneering in‑silico platform designed to transform aortic aneurysm surgery, according to a recent press release announcement made on EuropaWire. Developed by LivGemini, RBF Morph, INSA and Université de Rennes (UnivREN) in collaboration with Rennes University Hospital, PANDORA creates patient‑specific “digital twins” of the aorta by combining AI‑driven image analysis, mesh‑morphing algorithms and high‑performance simulations.

Surgeons can run virtual procedures on these personalized models to evaluate potential complications—such as graft kinking, impaired coronary perfusion and abnormal wall stresses—before entering the operating room. The goal is to guide prosthesis selection and surgical strategy with objective, data‑backed insights rather than relying solely on individual experience.

Offered under a B2B2B licensing model, the software will be integrated by medical‑device manufacturers into their planning systems for hospitals and clinics. Project coordinator Dr. Leonardo Geronzi, a Forbes “Top Under 30” in Science & Health, says PANDORA aims to shorten operating times, improve postoperative outcomes and reduce costs. After clinical validation at Rennes, LivGemini plans to industrialize the solution for broader market release later this year.

SOURCE: EuropaWire